Abiomed Inc (ABMD)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

22 CHERRY HILL DR DANVERS, MA 01923

ABIOMED is a provider of mechanical circulatory support devices and it provides a range of care in heart recovery to heart failure patients. Co. develops, manufactures and markets products that are used in the cardiac catheterization lab, or cath lab, by cardiologists and in the heart surgery suite by heart surgeons for patients who require hemodynamic support prophylactically or emergently before, during or after angioplasty or heart surgery procedures. Co.'s products include: the Impella 2.5 catheter, the Impella 5.0 catheter, Impella LD, AB5000 Circulatory Support System, the BVS 5000 Biventricular Support System, and AbioCor implantable replacement heart.

Data as of 2020-07-04
Market Cap11.884 Billion Shares Outstanding45.044 Million Avg 30-day Volume521.59 Thousand
P/E Ratio59.7 Dividend Yield EPS4.42
Price/Sales18.768 Price cash flow ratio38.4 Price free cash flow ratio54.4
Book Value23.65 Price to Tangible Book11.67 Alpha0.02
Short Interest Ratio % Short Interest to Float R-squared0.10015
BETA0.918483 52-week High/Low285.77 / 119.01 Stddev0.123594
View SEC Filings from ABMD instead.
Q1 2020 All Institutions Hedge Funds 1
Filers who had this stock in their top 10: 3 2 (0.13%)
13F Filers holding this stock: 393 81 (5.3%)
Aggregate 13F shares on 03/31/2020: 42.375 Million 16.699 Million
Aggregate 13F shares on 12/31/2019: 44.245 Million 15.803 Million
Percent change: -4.23% 5.67%
Funds creating new positions: 44 12
Funds Adding to an existing position: 145 36
Funds closing out their position: 92 30
Funds reducing their position: 151 29
Heat Map Ranking for 03/31/2020 234
Heat Map Ranking for 12/31/2019 74
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ABMD (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ABMD BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

7.5 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SUTTER MARTIN P

  • Director
  • 10% Owner
0 2020-07-02 3

ROSE ERIC A MD

0 2020-06-16 1

PUHY DOROTHY E

  • Director
26,487 2020-06-05 2

TOMSICEK MICHAEL JOHN

  • Director
0 2020-06-05 0

GREENFIELD ANDREW J VP, CHIEF COMMERCIAL OFFICER

  • Officer
51,075 2020-05-29 4

WEBER DAVID M CHIEF OPERATING OFFICER

  • Officer
140,429 2020-05-29 3

HOWLEY MICHAEL G VP, GLOBAL SALES & MARKETING

  • Officer
51,365 2020-05-29 4

MINOGUE MICHAEL R CHAIRMAN, PRESIDENT, CEO

  • Officer
  • Director
494,111 2020-05-29 4

TRAPP TODD A VICE PRESIDENT, CFO

  • Officer
9,380 2020-05-29 3

THOMAS PAUL

  • Director
8,920 2020-03-02 3

DOLLENS RONALD W

  • Director
21,316 2020-01-02 0

VAN GORDER CHRIS

  • Director
6,621 2019-08-07 1

RIVET JEANNINE M

  • Director
7,999 2019-08-07 1

BOLT WILLIAM J SVP, QA AND REGULATORY AFFAIRS

  • Officer
61,381 2019-05-24 0

MCLEOD IAN VP, CORPORATE CONTROLLER

  • Officer
7,079 2018-02-28 0

TERMEER HENRI A

  • Director
345,533 2016-08-09 0

AUSTEN W GERALD

  • Director
87,241 2015-08-12 0

BOWEN ROBERT CHIEF FINANCIAL OFFICER

  • Officer
76,265 2015-05-15 0

LATAIF LOUIS E

  • Director
111,175 2015-04-29 0

O CONNELL DESMOND JR

  • Director
67,062 2011-04-01 0

ABIOMED INC

  • 10% Owner
No longer subject to file 2010-03-24 0

SUTHERBY DANIEL J CFO, CAO

  • Officer
43,354 2008-09-16 0

FITCH PATRICIA A. VICE PRESIDENT OF SALES

  • Officer
5,000 2008-05-23 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

PUHY DOROTHY E - Director

2020-06-05 S 7,500 $250.00 d 15,152 26,487.00 direct yes

WEBER DAVID M - Officer CHIEF OPERATING OFFICER

2020-05-29 A 3,033 a 124,932 140,429.00 direct

HOWLEY MICHAEL G - Officer VP, GLOBAL SALES & MARKETING

2020-05-29 A 2,206 a 2,206 51,365.00 direct

GREENFIELD ANDREW J - Officer VP, CHIEF COMMERCIAL OFFICER

2020-05-29 A 2,476 a 39,043 51,075.00 direct

MINOGUE MICHAEL R - Director - Officer CHAIRMAN, PRESIDENT, CEO

2020-05-29 A 20,898 a 20,898 494,111.00 direct

HOWLEY MICHAEL G - Officer VP, GLOBAL SALES & MARKETING

2020-05-29 A 600 a 30,855 51,365.00 direct

TRAPP TODD A - Officer VICE PRESIDENT, CFO

2020-05-29 A 6,530 a 6,530 9,380.00 direct

WEBER DAVID M - Officer CHIEF OPERATING OFFICER

2020-05-29 A 5,000 a 5,000 140,429.00 direct

MINOGUE MICHAEL R - Director - Officer CHAIRMAN, PRESIDENT, CEO

2020-05-29 A 10,567 a 231,629 494,111.00 direct

GREENFIELD ANDREW J - Officer VP, CHIEF COMMERCIAL OFFICER

2020-05-29 A 4,896 a 4,896 51,075.00 direct

TRAPP TODD A - Officer VICE PRESIDENT, CFO

2020-05-29 A 3,500 a 9,380 9,380.00 direct

GREENFIELD ANDREW J - Officer VP, CHIEF COMMERCIAL OFFICER

2020-05-16 F 214 $184.92 d 37,187 48,599.00 direct

MINOGUE MICHAEL R - Director - Officer CHAIRMAN, PRESIDENT, CEO

2020-05-16 F 4,546 $184.92 d 221,062 483,544.00 direct

WEBER DAVID M - Officer CHIEF OPERATING OFFICER

2020-05-16 F 356 $184.92 d 122,829 137,396.00 direct

TRAPP TODD A - Officer VICE PRESIDENT, CFO

2020-05-16 F 310 $184.92 d 5,880 5,880.00 direct

MINOGUE MICHAEL R - Director - Officer CHAIRMAN, PRESIDENT, CEO

2020-05-16 F 1,632 $184.92 d 225,608 483,544.00 direct

HOWLEY MICHAEL G - Officer VP, GLOBAL SALES & MARKETING

2020-05-16 F 620 $184.92 d 30,255 50,765.00 direct

GREENFIELD ANDREW J - Officer VP, CHIEF COMMERCIAL OFFICER

2020-05-16 F 620 $184.92 d 36,567 48,599.00 direct

HOWLEY MICHAEL G - Officer VP, GLOBAL SALES & MARKETING

2020-05-16 F 210 $184.92 d 30,875 50,765.00 direct

WEBER DAVID M - Officer CHIEF OPERATING OFFICER

2020-05-16 F 930 $184.92 d 121,899 137,396.00 direct

WEBER DAVID M - Officer CHIEF OPERATING OFFICER

2020-05-15 F 1,187 $184.27 d 123,631 137,396.00 direct

SUTTER MARTIN P - Director

2020-05-15 G 700 d 188,239 188,239.00 direct

MINOGUE MICHAEL R - Director - Officer CHAIRMAN, PRESIDENT, CEO

2020-05-15 F 8,506 $184.27 d 229,303 483,544.00 direct

HOWLEY MICHAEL G - Officer VP, GLOBAL SALES & MARKETING

2020-05-15 F 267 $184.27 d 31,085 50,765.00 direct

GREENFIELD ANDREW J - Officer VP, CHIEF COMMERCIAL OFFICER

2020-05-15 F 267 $184.27 d 37,401 48,599.00 direct

HOWLEY MICHAEL G - Officer VP, GLOBAL SALES & MARKETING

2020-05-15 F 1,486 $184.27 d 31,352 50,765.00 direct

WEBER DAVID M - Officer CHIEF OPERATING OFFICER

2020-05-15 F 446 $184.27 d 123,185 137,396.00 direct

GREENFIELD ANDREW J - Officer VP, CHIEF COMMERCIAL OFFICER

2020-05-15 F 1,489 $184.27 d 37,668 48,599.00 direct

MINOGUE MICHAEL R - Director - Officer CHAIRMAN, PRESIDENT, CEO

2020-05-15 F 2,063 $184.27 d 227,240 483,544.00 direct
Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments